Clinical Study
Clinical Characteristics and Risk Factors of Recurrent Mooren’s Ulcer
Table 4
Clinical outcomes of affected eyes.
| | Variables | Total () | Recurrent group () | Nonrecurrent group () | χ2/t value | |
| | Inpatient days | 11 (8, 16) | 12 (8, 16) | 11 (8, 15) | −0.575 | 0.565 | | Visual Acuities | | Initial V/A | | | | 4.332 | 0.228 | | <0.01 | 19 (19) | 10 (22) | 9 (16) | | | | 0.01~0.1 | 23 (23) | 14 (31) | 9 (16) | | | | 0.1~0.4 | 36 (36) | 13 (29) | 23 (42) | | | | 0.4~1 | 22 (22) | 8 (18) | 14 (26) | | | | Final V/A | | | | 3.271 | 0.352 | | <0.01 | 18 (18) | 9 (20) | 9 (17) | | | | 0.01~0.1 | 22 (22) | 13 (29) | 9 (16) | | | | 0.1~0.4 | 36 (36) | 15 (33) | 21 (38) | | | | 0.4~1 | 24 (24) | 8 (18) | 16 (30) | | |
|
|
V/A: visual acuities.
|
